April is Youth Cancer Awareness Month. Younger people face unique challenges when it comes to cancer that are often inadequately addressed. And the rates of early onset cancers are rising. But there is much to be done! And we can do it!

Look what arrived today!

👇👇study of women with obesity related cancers vs controls. - ⬆️risk of mortality with more CVD abnormalities for cases and controls -CVD abnormalities NOT associated with ⬆️all‐ cause mortality risk in those receiving cardiotoxic treatment. tinyurl.com/2p2afxzr

🌟Share your insights on strategies for implementing PROMs in clinical practice - participate in 4 online survey rounds (15-20 mins each) Sign up now at ugent.qualtrics.com/jfe/form/SV_... Your input is invaluable in improving patient outcomes. 💪

Our paper on experiences of managing lymphoedema risk after cancer is out highlighting main barriers and potential solutions. See tinyurl.com/yc4xaz4k

NEW PODCAST: Fear of cancer recurrence is a major concern for survivors—how can we better support them? Hosted by @bogda-koczwara.bsky.social with Prof Sophie Lebel + A/Prof Ben Smith 🔗 Listen now: t.ly/L5qvM #CancerSurvivorship #FearOfCancerRecurrence #FCR #OncologyCare #CanSky #OncSky #MedSky

The first edition of series 2 of the podcast is out! Check it out here tinyurl.com/c5v3x75z

I am humbled and honoured to be appointed as the inaugural Director of the Australian Research Centre for Cancer Survivorship. There is so much we can do! tinyurl.com/yp8857r6

This World Cancer Day I think of all the patients whose journeys I shared over the past 30 years (yes, 30). This photo of one of my patients, who in between chemotherapies found time to be a clown doctor brings back so many emotions. Never forgotten!

Must read 👇👇👇 "diagnosis of cancer marks the beginning of two fights: one against the disease and the other against financial ruin. Sadly, the term financial toxicity connotes benignity in its clinical detachment" tinyurl.com/2asbwv9k

A case-control study showing an association between CVD and advanced stage of breast cancer at diagnosis, independent of delayed diagnosis and shared risk. Time to focus on the crosstalk between CVD and cancer! jamanetwork.com/journals/jam...

A new dawn to mark the start of 2025. Happy New Year friends!

Amazing paper in @thelancet.bsky.social evidencing something we argue in #publichealth the whole time: the opportunity cost of increasingly expensive medications 'During 2000–20, NHS coverage of new drugs displaced more population health than it generated.' www.thelancet.com/journals/lan...

On the commercial-political-emotional success of the alternative, evidence-free wellness movement: "You can look like us, feel like us, their chorus goes, if you follow our rules and purchase our powders" from @elainegodfrey.bsky.social www.theatlantic.com/politics/arc...

Hot of the press from @proteuspros - an infographic explaining the value of PROs! Note - they need to start as parr of the clinical encounter to benefit patients and society. tinyurl.com/3m594fhk

Two weeks until the #MASCC25 Conference Scholarship deadline on December 18! All other abstracts (including other award/scholarship applications) are due by January 8, 2025. mascc.org/annualmeetin... #SuppOnc #SurvOnc #GlobOnc #PallOnc #Oncology @oncoalert.bsky.social

I hope you get a chance to look after yourself soon Eric. And by extension, the patients 🤗🙏 www.bmj.com/content/364/...

If there is only one thing you will read today - make it this one! So many lessons on how to care: -illuminate the personhood -understand life outside the hospital -practical compassion -sit with darkness tinyurl.com/4h2u476m

Another great starter pack to follow: go.bsky.app/PowhjKD #CanSky #MedSky #OncoSky #advocates

SONIA trial - Pts with ER+ breast cancer beginning treatment in the metastatic setting randomized to 1st line vs 2nd line use of CDK4/6 inhibitor (+ endocrine therapy). No sig difference in PFS. www.nature.com/articles/s41...

Very good to see more de-escalation trials publishing in HER2 positive early breast cancer. Here the HELEN-006 trial. www.thelancet.com/journals/lan...

This is how we should be doing Oncology trials - the Dutch SONIA trial looking at treatment sequencing of CDK 4/6 inhibitors in advanced breast cancer. A self funding efficiency trial! #oncsky www.nature.com/articles/s41...

Cervical cancer mortality in US women younger than 25 years significantly declined between 2016 and 2021, likely due to the widespread adoption of HPV vaccination. ja.ma/4i9ghPC

Improved survival with neoadjuvant therapy for #TNBC KEYNOTE-522 at med follow-up of 75.1 mo 60 mo OS: 86.6% for pembro-chemo vs 81.7% placebo-chemo tinyurl.com/nhb7ze3v

Grade 1-2 treatment-related irAEs in the first cycle of therapy were associated with longer overall survival compared to no irAEs from checkpoint inhibitors. #survonc #supponc doi.org/10.1093/jnci...

Our summary of emerging challenges in cardio-oncology. If you are interested in this field join GCOS. Post behind paywall but you can join for free. tinyurl.com/25wf9utu

A moment of pure joy in my work as the Editor of a journal. The feedback from a reviewer taken not as a hassle but an opportunity to spark curiosity and doing something about it

Out now - our systematic review on hypothalamic-pituitary-adrenal dysfunction in people with cancer doi.org/10.1002/cam4... -17 case control studies -16 showing alteration - 6 looked at outcomes & showed correlation with fatigue, stress, sleep and memory changes.